Premium Company Profile: Encysive Pharmaceuticals

Publication Date	November 2007
Publisher	Datamonitor
Product Type	Report
Pages	50
ISBN Number	not applicable
Product Code	DAT08653

Price

£265.00
approximately: $386 | €306

PDF

PRINT £315 ($459 | €364)

Order above formats by FAX

Summary

Encysive Pharmaceuticals (formerly known as Texas Biotechnology) is a biopharmaceutical company focused on cardiovascular and inflammatory diseases such as: heparin-induced thrombocytopenia (HIT), pulmonary hypertension, essential hypertension, chronic heart failure, multiple sclerosis, asthma, and atherosclerosis.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Encysive is a biopharmaceutical company focused on the discovery, development and commercialization of novel, synthetic, small molecule compounds to address cardiovascular and inflammatory diseases.

The company's total revenues increased at a CAGR of 21% during 2002-2006, from $8 million to $18 million. This represents an absolute total growth of +$10 million for total revenues. The company's biggest contributor to revenue growth during 2002-2006 was royalties from sales of Argatroban.

The company's biggest contributor to sales growth out to 2010 will be the product sales of Thelin. Revenues from Thelin are expected to increase at a CAGR of 328.7%, from $0.3 million in 2006 to $108.4 million in 2010. This represents an absolute growth of +$108.1 million, which is 82% of Encysive's total forecast growth.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Table Of Contents
- Overview
- Catalyst
- Summary
- Company Structure
- Company Overview And Key Facts
- Business Description
- History
- Locations And Subsidiaries
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Geographic Segment Performance
- Products & Services
- Marketed Products
- Pipeline Products
- Historical Product Sales
- Ac Forecast Product Sales
- Competitors And Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- Swot Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery And Product Development
- Sales
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
List Of Key Employees
- Key Employee Biographies
- Financial And Operational Overview
- Financial And Operational Overview
Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
Table Of Figures
- Figure 1: Encysive - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Encysive - Key Strategic Revenues, 2002-2006 ($ Mn)
- Figure 3: Encysive - Key Strategic Revenues, 2006-2010 ($ Mn)
Table Of Tables
- Table 1: Encysive - Key Facts
- Table 2: Encysive - Locations And Subsidiaries
- Table 3: Encysive - Year-End Share Price And Market Capitalization, 2002-2006 ($)
- Table 4: Encysive - Key Events Impacting Share Price Performance
- Table 5: Encysive - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: Encysive - Operating Cost Ratio Analysis, 2002-2006 (% Of Total Revenues)
- Table 7: Encysive - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: Encysive - Cash Flow, 2002-2006 ($ Mn)
- Table 9: Encysive - Revenue Breakdown, 2002-2006 ($ Mn)
- Table 10: Encysive - Geographic Breakdown, 2002-2006 ($ Mn)
- Table 11: Encysive - Marketed Products
- Table 12: Encysive - In-House Pipeline Products
- Table 13: Encysive - Collaboration Products
- Table 14: Encysive - Historical Product Sales, 2002-2006 ($ Mn)
- Table 15: Encysive - Forecast Sales, 2006-2010 ($ Mn)
- Table 16: Encysive - Key Competitors
- Table 17: Encysive - Key Suppliers
- Table 18: Encysive - Key Clients
- Table 19: Encysive - Key Shareholders
- Table 20: Encysive - Swot Analysis Summary
- Table 21: Encysive - Value Chain Analysis
- Table 22: Encysive - Scorecard
- Table 23: Encysive - Key Employees
- Table 24: Encysive - Financial And Operational Overview